Opioid-Related Complications Sending More Seniors to Hospital

Opioid-Related Complications Sending More Seniors to Hospital

Despite efforts to reduce the use of prescription opioids, a significant number of seniors continue to take them, and an increasing number of seniors are landing in the hospital because of opioid-related complications.

Between 2010 and 2015, the number of emergency room (ER) visits among seniors related to taking opioids more than doubled, while hospitalizations increased by 54%, according to a new report from the Agency for Healthcare Research and Quality (AHRQ). In 2015, there were more than 124,000 hospitalizations and 36,000 ER visits as a result of complications from opioids.

Researchers said that as seniors tend to be prescribed more drugs than younger adults, they are more susceptible not only to adverse events from opioids themselves because of body changes, but from the opioids interacting with other medications. Many seniors also have mental health issues, cognitive decline and dementia that, compounded with taking opioids, puts them at increased risk for adverse events such as falls or delirium that can lead to a hospital visit.

An associated AHRQ report found that between 2015 and 2016, about 20% of seniors – around 10 million – filled at least one opioid prescription and 7% – about 4 million – received four or more.

AHRQ Center for Evidence and Practice Director Arlene Bierman, MD, who worked on the first report, told HealthDay that healthcare providers can address the situation by using non-opioid pain medications or even non-drug treatments before opioids. And if opioids are deemed necessary, the lowest possible dose should be prescribed.


Jonathan Block

Jonathan Block

Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Breaking News – EpiPen Malfunction

Breaking News – EpiPen Malfunction

Just released from the FDA – Pfizer has informed the FDA that they are aware of several continuing problems that people are having using the EpiPen (epinephrine) and EpiPen Jr (epinephrine) auto-injectors and generic versions. Some of the problems are from user error and some from EpiPen malfunction. Here are…

ACE Inhibitors in the Time of Coronavirus

ACE Inhibitors in the Time of Coronavirus

Are you worried about ACE inhibitors and coronavirus? You may be hearing that one of the entry methods for the coronavirus in humans is by attaching to the ACE-2 enzyme. This has raised alarms among those with heart disease who use ACE inhibitors (with names ending in -pril, such as…

  • Advertisement